2361 — Sinohealth Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapHigh Flyer

Annual income statement for Sinohealth Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	178	202	324	357	396
Cost of Revenue
Gross Profit	106	130	193	159	223
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	110	125	228	302	285
Operating Profit	67.7	77.3	96.5	54.9	111
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	67.1	76.1	95.5	54.5	111
Provision for Income Taxes
Net Income After Taxes	54.4	65.3	72	54.2	101
Minority Interest
Net Income Before Extraordinary Items
Net Income	56.1	67.9	78.8	55.8	102
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	56.1	67.9	78.8	55.8	102
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.125	0.149	0.208	0.135	0.291
Dividends per Share